UgenTec
- Company typePrivate
- Founded2014
- HeadquartersHasselt, Belgium
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What UgenTec does
UgenTec NV is a Belgian-headquartered software company founded in 2014 that builds FastFinder, a cloud-based, AI-driven Software-as-a-Service platform for molecular diagnostic laboratories. FastFinder automates PCR sample-to-result workflows, including curve calling, QC, genotyping, and lab intelligence dashboards, and is sold as modular components (Workflow, Analysis, Insights, QC, Studio, Genotyper) plus validated Assay Plug-ins. The platform is deployed across clinical diagnostics, veterinary diagnostics, pharma/CRO, and agricultural genomics, with named users including OLV Hospital Aalst, Plymouth Lighthouse Lab, AZ Sint-Jan Brugge, CHU Lyon, Hvidovre Hospital, SES Vanderhave, Bejo Zaden, BASF, Sonic Health, and SpeeDx, alongside large institutional deployments such as the Belgian national COVID-19 program and the French UniHA purchasing group covering up to 35 hospital labs.
The company generates revenue primarily through annual SaaS subscriptions and OEM/assay-plugin licensing fees paid by diagnostic kit and instrument manufacturers (SpeeDx, R-biopharm, Serosep, MDxHealth, PathoFinder, Eurofins GeneScan, Fast Track Diagnostics/Siemens Healthineers, Tecan, Hamilton, Thermo Fisher, Roche) that bundle FastFinder with their kits and platforms. GTM combines direct enterprise field sales in Benelux and the US (Boston office opened in 2018) with channel partners such as DMark Biosciences for Canada and UniHA for France, supplemented by partner co-marketing and IVDR-focused educational webinars. The platform is built on Microsoft Azure, certified ISO 13485:2012 and CE-IVD, and complies with EU IVDR; AFNOR NF VALIDATION has been granted for five Eurofins kits and FDA 510(k) clearance obtained via the SeroSep EntericBio partnership.
UgenTec was profitable prior to September 2022, when Nordic private equity firm Summa Equity acquired a majority stake from HERANPartners, LRM, and other early shareholders, with management reinvesting. In January 2023, Summa combined UgenTec with Pierian and Seven Bridges to form Velsera, a $400M-backed precision medicine platform; UgenTec continues to operate its FastFinder business inside Velsera alongside expanded multi-omics capabilities.
UgenTec firmographics
Firmographics- Name
- UgenTec
- Legal name
- UgenTec NV
- Website
- https://ugentec.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
UgenTec industry classification
Industry- Product category
- Molecular Diagnostics Software
- NAICS
- Software Publishers (513210), In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (62151)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)
- akta.pro secondary industries
- Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD), Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Oncology Diagnostics (tumor profiling, MRD, liquid biopsy) (HLAAALAE), Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
Keywords
Where UgenTec is headquartered
LocationHeadquarters
- HQ city
- Hasselt
- HQ country
- Belgium
- HQ region
- Europe
Offices2 records
Markets served
UgenTec business model
Business model- GTM type
- B2B
- Offering type
- Software
Revenue model
- SaaS Software Licenses: FastFinder is a modular, clinical-grade Software-as-a-Service (SaaS) platform. Labs and assay providers subscribe to access workflow automation, analysis, QC, insights, and genotyping modules.
- OEM/Assay Plugin Licensing: Diagnostic assay and instrument partners (SpeeDx, R-biopharm, Roche, etc.) bundle FastFinder with their products, creating recurring licensing revenue.
- Enterprise Agreements: Large-scale agreements with government and hospital networks (UniHA, Belgian government) for COVID and broader diagnostic testing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Modular SaaS platform with multiple product tiers |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels7 records
UgenTec product offering
Product offeringCore offering
UgenTec provides FastFinder, an AI-powered, cloud-based software platform for molecular diagnostics laboratories. The platform automates PCR/qPCR assay interpretation, genotype calling, quality control, and LIMS integration for clinical diagnostic labs, assay developers, and instrument manufacturers.
Product overview
UgenTec's FastFinder is a modular, clinical-grade Software-as-a-Service platform for molecular diagnostic labs. The core platform combines AI-powered data analysis with comprehensive lab workflow orchestration. The modular architecture includes six integrated components: FastFinder Analysis (automated curve calling and result interpretation), FastFinder Workflow (sample-to-result orchestration), FastFinder Insights (lab intelligence dashboards), FastFinder QC (quality control monitoring), FastFinder Studio (assay configuration and rule management), and FastFinder Genotyper (end-point PCR genotyping). Assay Plug-ins provide validated configurations for specific commercial kits. The platform supports multiple molecular modalities including PCR (real-time, end-point, digital), LAMP, serology, mass spectrometry, and NGS, serving clinical diagnostics, veterinary, pharma, and agricultural genomics markets.
Differentiator
Problem solved
Functional benefit
Brands
- FastFinder: Modular, clinical-grade Software-as-a-Service platform for molecular diagnostic labs that automates sample flow, result analysis, QC, and lab insights using AI.
- FastFinder Workflow
- FastFinder Analysis
- FastFinder Insights
- FastFinder QC
- FastFinder Genotyper
- FastFinder Studio
Products and services
- FastFinder Workflow
- FastFinder Analysis
- FastFinder Insights
- FastFinder QC
- FastFinder Studio
- FastFinder Genotyper
Quantifiable outcome
- 50% reduction in qPCR curve analysis and processing time
- +5 more outcomes
Companies that use UgenTec
Customer profileNamed customers12 records
Segments6 records
Ideal customer profiles5 records
UgenTec technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
AI capability9 records
Feature8 records
UgenTec partnerships and signals
Strategic signalPartnerships
20 partnerships are on record, tiered strategic, core and regional.
- Medicinal GenomicsstrategicPartnership adds FastFinder software to MGC's microbial testing platform for cannabis testing. AI-powered technology minimizes manual labor, inconsistencies and errors.
- Thermo Fisher ScientificcoreCollaborative agreement to commercialize FastFinder Assay Plug-in for Thermo Fisher TaqPath COVID-19 CE-IVD RT-PCR kit and TaqPath COVID-19, Flu A/B, RSV Combo kit.
- TetraSciencestrategicUgenTec joined Tetra Partner Network to help customers accelerate scientific outcomes in molecular workflows using Tetra Data. Enables scientists to use Tetra Data for workflow automation and insights.
- Roche DiagnosticscoreUgenTec and Roche Diagnostics partner to enhance sample-to-result workflows on Roche Flow with FastFinder software. Joint go-to-market collaboration for molecular diagnostics labs.
- TecancorePartnership to develop fully integrated, sample-to-result solutions for PCR workflows. Combines Tecan's liquid handling and automation expertise with UgenTec's FastFinder software. Partnership forms basis of OEM IVD platforms through Tecan Syngence.
- DMark BiosciencesregionalCanada distributor agreement for FastFinder software platform covering all products for routine diagnostic molecular lab market.
- MolGenstrategicCollaboration bringing high-throughput rapid LAMP SARS-CoV-2 test to diagnostic labs. Combines MolGen's PurePrep instrumentation with FastFinder AI-based software platform.
- UniHAregionalFramework agreement with French hospital purchasing group for FastFinder PCR software. Up to 35 hospital labs can adopt FastFinder Analysis for COVID and other pathogen testing.
- Eurofins GeneScan TechnologiescoreAI collaboration on assay plugins for Eurofins portfolio of molecular biology kits on FastFinder. Enables deployment at scale with automated result reporting for food, feed and seed testing.
- Sentinel DiagnosticsstrategicThree-way partnership with Hamilton and Sentinel on SENTiNAT 200 sample-to-result platform. FastFinder provides workflow software for Hamilton Microlab RT-STARlet-based molecular diagnostics.
- SerosepcorePartnership adds Serosep EntericBio assay range to FastFinder platform. FDA-submitted EntericBio GI qPCR testing now supported with standardized and AI-automated diagnostic interpretation.
- Hamilton RoboticscoreFounding partner of Molecular Automation Network. Collaboration on end-to-end automated hard- and software systems for medium-to-high throughput diagnostic laboratories. Joint business opportunities and technical expertise exchange.
- MDxHealthstrategicPartnership for software to support interpretation of molecular test results for SelectMDx and ConfirmMDx for Prostate Cancer tests. AI software to streamline testing procedures.
- Fast Track Diagnostics (Siemens Healthineers)corePartnership to offer interpretation software for all FTD real-time PCR multiplex kits. FastFinder integrated for Applied Biosystems 7500 and LightCycler 480 platforms.
- R-biopharmcorePartnership to develop RIDA SEEKS software for automated PCR analysis of R-biopharm's clinical PCR kits. Covers development, regulatory approval and launch for RIDA GENE MDx and RIDA PRECISION Companion Diagnostics.
- PathoFinderstrategicRollout of multiplex PCR interpretation software for PathoFinder's 2SMART syndromic infectious disease panels. Deployed in 10+ labs across Europe and Middle East on Roche Cobas and Lightcycler systems.
- SpeeDxcoreCollaboration on artificially intelligent analysis plugin for ResistancePlus MG test. FastFinder provides automated interpretation of Mycoplasma genitalium test results and 23S rRNA resistance mutations.
- Global Alliance for Genomics and HealthstrategicUgenTec is part of GA4GH, an organization that enables responsible genomic data sharing for the benefit of human health.
- MicrosoftstrategicGold partner in Microsoft partner program. FastFinder deployed on Microsoft Azure cloud infrastructure.
- Molecular Automation NetworkstrategicConsortium of companies active in molecular diagnostics and automation. Purpose is to connect MDx industry enabling more complete solutions and end-to-end workflows.
Scale indicators8 records
Recent moves9 records
Expansion highlights7 records
UgenTec competitors and assessment
Company assessmentDirect peers
- Sophia Genetics: AI-driven platform for clinical genomics and molecular data interpretation across cancer, rare disease and inherited disorders. Directly comparable to UgenTec as a clinical-grade AI software vendor serving diagnostic labs with multi-modal interpretation (NGS, PCR-adjacent workflows) on a SaaS basis.
- Genoox: Cloud-based AI platform for genomic data management and clinical interpretation serving diagnostic labs and clinicians. Directly comparable to UgenTec's positioning as a SaaS interpretation layer between raw instrument output and clinical reporting, with similar target customers in molecular diagnostics.
- Fabric Genomics: Clinical genomics interpretation platform (formerly Omicia) providing AI-driven variant interpretation for hereditary disease and oncology labs. Comparable to UgenTec in offering clinical-grade interpretation software on cloud infrastructure to diagnostic customers, with adjacent but overlapping molecular modalities.
Broad incumbents
- DNAnexus: Enterprise cloud platform for genomic and biomedical data management serving pharma, clinical labs and large consortia. Comparable to UgenTec as a regulated cloud-based bioinformatics environment for molecular workflows, with broader scope across pharma R&D and translational research.
- QIAGEN Digital Insights: Bioinformatics and clinical interpretation suite (formerly QDI) covering NGS, variant interpretation and molecular workflow software. Directly comparable to UgenTec's clinical interpretation focus, with a much broader portfolio and established position as an incumbent in clinical lab software.
- Bio-Rad CFX Maestro: PCR analysis software bundled with Bio-Rad's CFX real-time PCR instruments. Directly comparable to FastFinder as instrument-vendor-supplied PCR interpretation software, representing the alternative distribution model that competes with UgenTec's independent OEM-agnostic platform.
- Thermo Fisher Scientific (Applied Biosystems software): Design & Analysis software for Applied Biosystems QuantStudio and 7500 real-time PCR instruments. Comparable as instrument-vendor PCR interpretation software; represents both a competitor to UgenTec and a major OEM distribution partner, illustrating the dual-edged nature of the relationship.
- Roche Diagnostics: LightCycler and cobas PCR instrument franchise with proprietary analysis software. Comparable to UgenTec as a major OEM partner for sample-to-result workflows (Roche FLOW with FastFinder) while simultaneously offering in-house PCR interpretation software that could compete with FastFinder.
Others
- Seven Bridges: Bioinformatics platform for NGS and multi-omics data analysis serving pharma and research. Now a sister company inside Velsera alongside UgenTec following the 2023 Summa Equity combination — comparable as a precision-medicine software asset within the same parent group.
- Pierian: Clinical genomics interpretation and reporting platform for hereditary disease and oncology labs. Now a sister company inside Velsera alongside UgenTec and Seven Bridges — comparable as a clinical interpretation software asset serving diagnostic labs, with overlapping customer base to UgenTec.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
UgenTec social profiles
Digital presenceUgenTec compliance and trust
Trust signalCompliance6 records
UgenTec financial estimates
Financial estimateRevenue estimate
Valuation estimate
UgenTec leadership team
Management profileNumber of profiles
Profiles9 records
UgenTec funding detail
Funding detailFunding overview
Funding rounds5 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
UgenTec M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about UgenTec
What does UgenTec do?
UgenTec provides FastFinder, an AI-powered, cloud-based software platform for molecular diagnostics laboratories. The platform automates PCR/qPCR assay interpretation, genotype calling, quality control, and LIMS integration for clinical diagnostic labs, assay developers, and instrument manufacturers.
Is UgenTec a public or private company?
UgenTec is a private company. It is classified as private equity controlled and is currently acquired.
When was UgenTec founded?
UgenTec was founded in 2014. It employs 11 to 50 people.
Where is UgenTec based?
UgenTec is headquartered in Hasselt, Belgium, in the Europe region.
How does UgenTec make money?
Three revenue lines are on record. SaaS Software Licenses are the primary driver. The others are OEM/Assay Plugin Licensing and enterprise Agreements.
Who are UgenTec's main competitors?
Direct peers on record are Sophia Genetics, Genoox and Fabric Genomics. Broad incumbents are DNAnexus, QIAGEN Digital Insights, Bio-Rad CFX Maestro, Thermo Fisher Scientific (Applied Biosystems software) and Roche Diagnostics. Others are Seven Bridges and Pierian.
Does UgenTec have an API?
No public API is recorded for UgenTec.
What industry is UgenTec in?
UgenTec's product category is Molecular Diagnostics Software. Its primary akta.pro industry code is HLAGAJAF, Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D), with a secondary code of HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD). Its NAICS code is 513210 and its SIC code is 2835.